[Surgical results of valvular heart disease combined with myocardial revascularization]

Y Arai1, R Sakata, T Koshiji

  • 1Department of Cardiovascular Surgery, Kumamoto Central Hospital, Japan.

Insights

Combined valvular and coronary artery bypass surgery had significant risk factors for hospital death. Ischemic mitral regurgitation, renal failure, and bypass duration were key predictors, with ischemic mitral regurgitation being a strong indicator.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Risk Factor Analysis

Context:

  • Examined 131 combined valvular and coronary artery bypass surgery cases (Oct 1988-Dec 1999).
  • Represented 8.0% of coronary revascularization and 15.3% of valvular heart disease surgeries.
  • Patient cohort: 84 men, 43 women; mean age 68.9 years.

Purpose:

  • Identify pre- and perioperative risk factors for hospital mortality.
  • Analyze predictors of death following combined cardiac procedures.
  • Evaluate the safety and outcomes of combined valvular and coronary artery bypass surgery.

Summary:

  • Ischemic mitral regurgitation, chronic renal failure, and cardiopulmonary bypass duration identified as major predictors of hospital death.
  • Ischemic mitral regurgitation was a significant predictor (p=0.03), with a 13.1% mortality rate in affected cases versus 3.2% in others.
  • Overall results were not unfavorable, suggesting elective combined procedures are feasible for severe coronary artery disease.

Impact:

  • Highlights critical risk factors for combined valvular and coronary artery bypass surgery.
  • Suggests combined procedures can be safely performed electively in select patients.
  • Underscores the need for further research into surgical outcomes for ischemic mitral regurgitation.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.